Css LLC Kala Pharmaceuticals, Inc. Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $181,789 - $279,094	-29,133 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $9,420 - $13,184	1,500 Added 5.43%	29,133 $198,000
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $92,250 - $136,653	12,300 Added 80.22%	27,633 $207,000
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $123,967 - $205,222	-14,882 Reduced 49.25%	15,333 $161,000
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $115,723 - $265,589	30,215 New	30,215 $266,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.69M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.